The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers

Am J Drug Alcohol Abuse. 2009;35(5):316-9. doi: 10.1080/00952990903060150.

Abstract

Objective: The purpose of this study is to examine the effects of zonisamide on ethanol self-administration and subjective effects in risky drinkers using a human laboratory paradigm.

Method: We conducted a double-blind, placebo-controlled study of the effects of zonisamide 100 mg on ethanol self-administration and urge to drink in risky drinkers (N = 10) ( [1] ).

Result: During the second hour of a 2-hour self-administration session ethanol consumption was 50% lower in the zonisamide group as compared to the placebo group. Urge to drink was also significantly lower under the zonisamide condition.

Conclusion: These results indicate that a single dose of zonisamide reduces urge to drink and the quantity of ethanol self-administered by risky drinkers during their second hour of access to alcohol.

Scientific significance: Zonisamide may help individuals drinking at risky levels reduce their intake of alcohol.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alcohol Drinking / drug therapy*
  • Anticonvulsants / therapeutic use
  • Cross-Over Studies
  • Double-Blind Method
  • Ethanol / administration & dosage*
  • Female
  • Humans
  • Isoxazoles / therapeutic use*
  • Male
  • Middle Aged
  • Self Administration
  • Surveys and Questionnaires
  • Time Factors
  • Zonisamide

Substances

  • Anticonvulsants
  • Isoxazoles
  • Ethanol
  • Zonisamide